Earlier today, we reported financial results and provided business updates for the third quarter of 2024. For the latest episode of our #IRInsights series, members of our executive team sat down to provide more insight into our financial performance and upcoming late-stage pipeline milestones. Watch the full video here: https://lnkd.in/e5Dgp-nF
Moderna
Biotechnology Research
Cambridge, Massachusetts 630,782 followers
Our mission is to deliver the greatest possible impact to people through mRNA medicines.
About us
At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using mRNA as a drug are significant and far-reaching and could meaningfully improve how medicines are discovered, developed and manufactured. To learn more, visit www.modernatx.com. This Moderna page is not the appropriate place to report adverse events (side-effects) for any products. If you are or someone you know is experiencing a side effect, please reach out to your healthcare professional. Moderna is continuously monitoring the safety of its products. We encourage you to report any side effects directly to us at 1‑866‑MODERNA (1‑866‑663‑3762).
- Website
-
https://www.modernatx.com/?tc=soc_7y8qkt&cc=1004
External link for Moderna
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Cambridge, Massachusetts
- Type
- Public Company
- Founded
- 2010
- Specialties
- Biotechnology and mRNA Therapeutics
Locations
-
Primary
Get directions
200 Technology Sq
Cambridge, Massachusetts 02139, US
-
Get directions
1 Upland Rd
Norwood, Massachusetts 02062, US
Employees at Moderna
-
Jean-Christophe Wüthrich
Business Technology Management | Strategic Planning & IT Governance | Service Management, Integration & Performance | Change Management | Sourcing…
-
Shawn Lipstein
Innovative UX & Product Leader | Critical Thinker | Strategic Visionary | Empathetic Manager | Driven Partner | Crystal Clear Communicator
-
Lukasz Wielochowski
Head of Moderna Enterprise Solution Hub in Poland
-
Karen Doolittle
MBA | PfMP, PgMP, PMP Pharmacovigilance Operations
Updates
-
Today, we reported financial results and provided business updates for the third quarter of 2024. Read more: https://lnkd.in/edz_Bdsx
-
-
Join us at the Boston Globe Media’s first annual Future of Medicine event on Nov. 13 to hear from Kyle Holen, our Head of Development, Oncology and Therapeutics who will be joined by Patrick Ott of Dana-Farber Cancer Institute and Jacalyn Rosenblatt of Beth Israel Deaconess Medical Center to discuss precision approaches shaping the future of cancer care. Learn more: https://lnkd.in/e87Q3Ppx
-
-
We're implementing AI use cases across our entire value chain—from research to commercialization—to help advance the development of #mRNA medicines. Discover how we’re leveraging generative AI and large language models to empower our employees and unlock innovative treatments. Read more from Fortune: https://lnkd.in/eFJXgKAt
-
Over the summer, the U.S. experienced one of the biggest #COVID19 waves in the past two years. In its updated guidance, the CDC recommends that people who recently had a COVID-19 infection should consider waiting up to three months from your first symptoms or, if the infection was asymptomatic, a positive test, to get their updated COVID-19 vaccine. So if you had COVID in August or earlier, you should get an updated vaccine this month! Learn more: https://lnkd.in/eP76aMXD
-
#TeamModerna brought their #Halloween spirit to work today! From spooky costumes to a pumpkin-painting contest, it’s been a day full of treats and artistic tricks 🎃👻
-
Vampires and latent #viruses might have more in common than you think! 👀😶 This #Halloween, watch to learn more about these scary viruses and how they work. 👻🦇
-
Can you get the updated #COVID vaccine and the #Flu shot at the same time? Are there any benefits to doing so? 💪🏽💉 Watch the latest episode of #CoffeeBreakScience, featuring Mary Bausch-Jurken, to find out! 🔎
-
Our Canadian manufacturing site, a 100,000-square-foot drug substance manufacturing facility located just outside Montreal in Laval, recently reached a major milestone — receiving a Drug Establishment License (DEL) from Health Canada. This certification allows us to manufacture drug substances on Canadian soil and positions Laval as the first Moderna site outside of the United States to achieve this authorization. Read more about our Laval facility, a pillar of our global health strategy: https://lnkd.in/e6Ysucu5
-
-
Merck and Moderna announced today the initiation of the Phase 3 trial evaluating V940 (mRNA-4157), an investigational individualized neoantigen therapy (INT), in Combination with KEYTRUDA® (pembrolizumab) after neoadjuvant KEYTRUDA and chemotherapy in patients with certain types of non-small cell lung cancer (NSCLC). Read more: https://lnkd.in/ezG4A7hR
-